Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBioquell Regulatory News (BQE)

  • There is currently no data for BQE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Bioquell Plc

22 Feb 2016 10:15

RNS Number : 7219P
Nplus1 Singer Capital Markets Ltd
22 February 2016
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Bioquell Plc

 

(c) Name of the party to the offer with which exempt principal trader is connected:

 

Bioquell Plc

 

(d) Date dealing undertaken:

19 February 2016

 

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 10P

 

Sale

 

33,750

 

156.9p

 

155.9p

 

ORD 10P

 

Purchase

 

14,597

 

155.2p

 

155p

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

Date of disclosure:

22 February 2016

Contact name:

Kelly Morgan

Telephone number:

020 7496 3094

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERAKBDDKBKDQBB
Date   Source Headline
10th Mar 20087:00 amRNSFinal Results
9th Nov 200710:27 amRNSHolding(s) in Company
26th Oct 200710:13 amRNSSuperbug update.
2nd Oct 20071:29 pmRNSContract Award
12th Sep 20077:01 amRNSInterim Results
28th Jun 20073:38 pmRNSExercise of Options
11th Apr 20078:06 amRNSDirector/PDMR Shareholding
27th Mar 20078:48 amRNSDirector/PDMR Shareholding
27th Mar 20078:43 amRNSDirector/PDMR Shareholding
26th Mar 20077:01 amRNSFinal Results
21st Dec 200610:54 amRNSTotal Voting Rights
12th Dec 200611:39 amRNSHolding(s) in Company
19th Sep 20067:00 amRNSInterim Results
21st Aug 20061:43 pmRNSResult of EGM
19th Jul 200612:27 pmRNSNotice of EGM
2nd May 20069:55 amRNSDirector/PDMR Shareholding
27th Apr 20061:48 pmRNSAdditional Listing
11th Apr 20067:00 amRNSFinal Results
22nd Mar 20067:00 amRNS.Superbug. eradication trial
21st Dec 20057:00 amRNSResearch Update
26th Oct 20054:42 pmRNSAcquisition
26th Sep 20057:01 amRNSInterim Results
20th Apr 20052:27 pmRNSDirector Shareholding
15th Apr 20053:33 pmRNSHolding(s) in Company
11th Apr 20057:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.